Skip to main content

Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
bevacizumab
pegaptanib
ranibizumab
verteporfin
Description

In this report, we examined bevacizumab and other cancer medication use during pregnancy in the Sentinel Distributed Database (SDD). The study period includes data from January 1, 2001 to September 30, 2015. We distributed this request to 14 Sentinel Data Partners on July 21, 2016.

Deliverables (1)
Sentinel Modular Program Report: Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2001 - September 30, 2015
Analysis Type
Summary Table
Population / Cohort
Females 0 to 54 years of age with evidence of a live birth
Data Sources
Sentinel Distributed Database (SDD)